Research on the Individualized Treatment Strategy for Extremely Preterm Infants With hsPDA Based on Biomarkers and Targeted Delivery Systems
NCT07374146
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Hemodynamically Significant Patent Ductus Arteriosus
Sponsor
Peking University Third Hospital